BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 23991627)

  • 1. Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?
    Zimmermann M
    Br J Pharmacol; 2013 Nov; 170(5):953-67. PubMed ID: 23991627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovering and targeting the basic mechanism of neurodegeneration: the role of peptides from the C-terminus of acetylcholinesterase: non-hydrolytic effects of ache: the actions of peptides derived from the C-terminal and their relevance to neurodegeneration.
    Greenfield S
    Chem Biol Interact; 2013 May; 203(3):543-6. PubMed ID: 23562497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neuroprotective effects of nicotine and acetylcholinesterase inhibitors: role of alpha4 and alpha7 receptors in neuroprotection.
    Akaike A; Takada-Takatori Y; Kume T; Izumi Y
    J Mol Neurosci; 2010 Jan; 40(1-2):211-6. PubMed ID: 19714494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of donepezil through inhibition of GSK-3 activity in amyloid-beta-induced neuronal cell death.
    Noh MY; Koh SH; Kim Y; Kim HY; Cho GW; Kim SH
    J Neurochem; 2009 Mar; 108(5):1116-25. PubMed ID: 19077054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of Readthrough Acetylcholinesterase Variants in the Brains of Alzheimer's Disease Patients.
    Campanari ML; Navarrete F; Ginsberg SD; Manzanares J; Sáez-Valero J; García-Ayllón MS
    J Alzheimers Dis; 2016 May; 53(3):831-41. PubMed ID: 27258420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virtues and woes of AChE alternative splicing in stress-related neuropathologies.
    Meshorer E; Soreq H
    Trends Neurosci; 2006 Apr; 29(4):216-24. PubMed ID: 16516310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine.
    Jiang X; Liu C; Zou M; Xie H; Lin T; Lyu W; Xu J; Li Y; Feng F; Sun H; Liu W
    Eur J Med Chem; 2021 Nov; 223():113663. PubMed ID: 34198150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting acetylcholinesterase splice variations in anticholinesterase-treated Alzheimer's disease patients.
    Darreh-Shori T; Hellström-Lindahl E; Flores-Flores C; Guan ZZ; Soreq H; Nordberg A
    J Neurochem; 2004 Mar; 88(5):1102-13. PubMed ID: 15009666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
    Lane RM; Potkin SG; Enz A
    Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
    Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 7-O-modified genistein derivative with acetylcholinesterase inhibitory effect, estrogenic activity and neuroprotective effect.
    Shi DH; Yan ZQ; Zhang LN; Wang YR; Jiang CP; Wu JH
    Arch Pharm Res; 2012 Sep; 35(9):1645-54. PubMed ID: 23054722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new allosteric sites and modulators of AChE through computational and experimental tools.
    Roca C; Requena C; Sebastián-Pérez V; Malhotra S; Radoux C; Pérez C; Martinez A; Antonio Páez J; Blundell TL; Campillo NE
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1034-1047. PubMed ID: 29873262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of neuroprotective effects of therapeutic acetylcholinesterase inhibitors used in treatment of Alzheimer's disease].
    Takatori Y
    Yakugaku Zasshi; 2006 Aug; 126(8):607-16. PubMed ID: 16880719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholinesterase variants in Alzheimer's disease: from neuroprotection to programmed cell death.
    Greenberg DS; Toiber D; Berson A; Soreq H
    Neurodegener Dis; 2010; 7(1-3):60-3. PubMed ID: 20173328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enhancement of the activity of C-terminally truncated, but not intact, acetylcholinesterase.
    Zimmermann M; Grösgen S; Westwell MS; Greenfield SA
    J Neurochem; 2008 Jan; 104(1):221-32. PubMed ID: 17986217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic regulation of acetylcholinesterase activity in Drosophila reveals the regulatory mechanisms of AChE inhibitors in synaptic plasticity.
    Kim W; Lee D; Choi J; Kim A; Han S; Park K; Choi J; Kim J; Choi Y; Lee SH; Koh YH
    Neurochem Res; 2011 May; 36(5):879-93. PubMed ID: 21305389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?
    Moss DE
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
    Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
    Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of donepezil against Abeta(1-40) neurotoxicity in rat septal neurons.
    Kimura M; Akasofu S; Ogura H; Sawada K
    Brain Res; 2005 Jun; 1047(1):72-84. PubMed ID: 15893738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.